Sarepta Therapeutics Inc (SRPT)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 1,901,979 1,640,348 1,504,993 1,403,300 1,243,336 1,104,982 1,003,434 975,683 933,013 876,047 835,184 765,786 701,887 645,564 600,082 573,356 540,099 495,074 450,191 407,496
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $1,901,979K ÷ $—K
= —

The receivables turnover ratio for Sarepta Therapeutics Inc for the period from March 31, 2020, to December 31, 2024, is not provided in the data. Receivables turnover ratio is a financial metric that measures how efficiently a company is able to collect payments from its customers on credit sales during a specific period.

Without the specific data points for receivables turnover, we are unable to analyze the trend or assess the effectiveness of Sarepta's credit and collection policies. A higher receivables turnover ratio typically indicates a more efficient collection process and better liquidity, while a lower ratio may signal potential issues with credit control or difficulty in collecting receivables.

It is important for investors and stakeholders to monitor receivables turnover over time to understand how well the company manages its credit sales and cash flow. More consistent and timely disclosure of financial data, including receivables turnover ratio, would provide a clearer picture of Sarepta Therapeutics Inc's financial performance and operational efficiency.